Gainers
- Curaleaf Holdings CURLF shares rose 2.34%, to close at $7.98, trading high after Friday's acquisition of Grassroots for $875 million.
- Zynerba Pharmaceuticals ZYNE shares rose 12.59%, to close at $12.16.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
Losers
- Aurora Cannabis ACB shares tumbled by 1.61%, eventually closing at $6.73.
- Aphria APHA shares tumbled by 3.29%, eventually closing at $6.18.
- Canopy Growth CGC shares tumbled by 1.76%, eventually closing at $34.86; subsidiary Canopy Rivers received a Health Canada License.
- Cronos Group CRON shares tumbled by 1.87%, eventually closing at $14.69.
- CannTrust Holdings CTST shares fell 1.44% to close at $2.73, as annoucements of forming an internal review committee did little to change investor's interest.
- Greenlane Holdings GNLN shares dropped by 2.9%, to close at $7.69.
- GW Pharmaceuticals GWPH shares fell 1.42% to close at $163.11.
- HEXO HEXO shares tumbled by 3.87%, eventually closing at $4.72.
- India Globalization Cap IGC shares tumbled by 5.0%, eventually closing at $1.33.
- Innovative Industrial IIPR shares tumbled by 8.31%, eventually closing at $113.07.
- iAnthus Capital Holdings ITHUF shares tumbled by 4.2%, eventually closing at $2.74.
- Akerna KERN shares fell 2.48% to close at $12.56.
- MedMen Enterprises MMNFF shares dropped by 2.54%, to close at $2.07.
- New Age Beverages NBEV shares dropped by 8.89%, to close at $3.69.
- OrganiGram Holdings OGI shares tumbled by 0.95%, eventually closing at $6.27.
- Pyxus International PYX shares fell 4.77% to close at $14.39.
- Tilray TLRY shares tumbled by 3.19%, eventually closing at $42.20.
- Therapix Biosciences TRPX shares tumbled by 3.77%, eventually closing at $2.30.
- cbdMD YCBD shares tumbled by 2.44%, eventually closing at $4.00.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
Top Stories:
The Week In Cannabis: A New Global Leader, Moves In UK And Colombia, ETFs Outperform
California And Industrial Hemp Challenge: Agricultural Commodity Or Cannabis
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.